NUS Medicine International Council

What NUS Medicine International Council does

The NUS Medicine International Council (NIC) is an advisory body established in 2005 within the NUS Yong Loo Lin School of Medicine, the public university's medical school founded in 1905. NIC operates as an invitational community of ambassadors and senior leaders from across geopolitics, macro-economics, socio-cultural domains, and medical science, convened by the Dean of NUS Medicine to champion the school's academic and research achievements and to extend its international connectivity. Day-to-day operations are led by a 5-person secretariat based at the Dean's Office in the NUHS Tower Block, 1E Kent Ridge Road, Singapore, and chaired by Kishore Mahbubani, former Singapore Ambassador to the United Nations.

NIC's core activities consist of three programmatic pillars: (1) annual flagship conferences, including the NIC Singapore Conference (scheduled 13-15 November 2025 and 10-11 June 2026) and the NIC Vatican Conference 2026 (28-30 October 2026), which serve as the primary engagement surface for members; (2) thematic Areas of Support across children's health, cancer, diabetes, and mental health resilience, which define the council's fundraising and thought-leadership focus; and (3) the Kickstart Initiative, a research commercialization and translation program with dedicated project, partner, progress, commercialisation, and webinar tracks designed to move NUS Medicine research toward practical application.

NIC does not operate as a commercial enterprise: there are no disclosed pricing models, customers, or revenue streams, and the council functions as a non-profit advisory committee supported by the parent institution. Its strategic relationships include a structural partnership with the National University Hospital (NUH), the primary clinical training partner for NUS Medicine, and a thematically oriented alliance with The Kallang Group via chairman and NIC member Keith Magnus. Membership is by Dean's invitation, positioning NIC as a curated senior network rather than a productized service.

Name

NUS Medicine International Council

Legal name

NUS Medicine International Council

Website

https://nic.nus.edu.sg

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

The NUS Medicine International Council is an invitational advisory body, founded in 2005 under NUS Yong Loo Lin School of Medicine, that convenes senior global leaders to champion the school's medical research, host flagship Singapore and Vatican conferences, and run the Kickstart research commercialization program.

Ownership category

akta.pro rank

Product category

Academic Medicine Advisory Council

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000)

akta.pro primary industry

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

• Medical research advisory
• Academic medicine council
• Medical research funding
• Healthcare leadership council
• Medical innovation programs

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Marketing channels2 records

Core offering

NIC operates as an advisory council and ambassador community that champions NUS Medicine's achievements in academic advancement and medical research. Its substantive offerings are the Kickstart Initiative (a research commercialization and innovation program supporting translation in children's health, cancer, diabetes, and mental health) and two flagship annual forums — the NIC Singapore Conference and the NIC Vatican Conference — which convene senior leaders across medicine, geopolitics, macro-economics, and socio-cultural topics.

Product overview

The NUS Medicine International Council (NIC) serves as an advisory and engagement body for the NUS Yong Loo Lin School of Medicine, supporting the school's international connectivity and research advancement. The NIC's primary programmatic offering is the Kickstart Initiative, which funds and supports medical research commercialization activities. The organization facilitates conferences (Singapore Conference, Vatican Conference) to engage its global network of leaders and supporters. The NIC operates as a unified advisory council rather than a product company.

Differentiator

Problem solved

Functional benefit

Products and services

• Kickstart Initiative A research commercialization and innovation program supporting the development and translation of NUS Medicine research projects into practical applications, with focus areas including ensuring a healthier future for children, taming cancer, curing diabetes, and mental health resilience and wellbeing. It is aimed at NUS Medicine-affiliated researchers and translational teams.
• NIC Singapore Conference Annual flagship forum convened in Singapore that brings together NIC members and invited leaders for open discourse on medical science, health innovations, geopolitics, macro-economics, and socio-cultural topics. It is aimed at NIC ambassadors, supporters, and senior leaders.
• NIC Vatican Conference Annual international flagship forum held at the Vatican that convenes NIC members and invited leaders to engage on medical science, health innovations, and broader global topics. It is aimed at NIC ambassadors, supporters, and senior leaders.
• NIC Membership Community An invitation-only community of ambassadors and supporters who are leaders in their respective fields, convened to champion achievements in academic advancement and medical research of NUS Medicine and to engage in open discourse on critical global issues.

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• National University Hospital (NUH)coreStrategic or Co-development PartnerNUH is the primary training institution for the NUS Yong Loo Lin School of Medicine. Clinical faculty of the medical school staff NUH, and together they play a profound role in shaping future leaders in healthcare, academic medicine, and public service in Singapore, Asia and beyond.
• The Kallang GroupcoreStrategic or Co-development PartnerChairman of The Kallang Group, Keith Magnus, serves as a member of NIC. The partnership provides leadership insights and organizational guidance to the council's activities and initiatives.
• NUS Yong Loo Lin School of MedicinecoreStrategic or Co-development PartnerThe NIC operates under the NUS Yong Loo Lin School of Medicine, supporting its mission to be a leading global university shaping the future. The council champions achievements in academic advancement and medical research.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Wellcome Trust: Large UK-based charitable foundation funding biomedical research and translation globally. Comparable in focus area (medical research commercialization and translation) but operates at vastly greater scale than NIC's Kickstart Initiative.

Regional players

• National Medical Research Council (NMRC) Singapore: Singapore's public body funding and coordinating clinical and translational medical research. Comparable in mission (advancing Singapore-based medical research) but a government funding agency rather than an advisory council.
• Agency for Science, Technology and Research (A*STAR) Singapore: Singapore's public-sector R&D agency advancing biomedical and translational research within the same national ecosystem as NIC. Comparable in supporting Singapore-based medical research commercialization, though at much greater scale and with broader mandate.

Direct peers

• Weill Cornell Medicine Board of Overseers: Overseers body for Weill Cornell Medical College, providing external guidance, fundraising advocacy, and program support. Directly comparable to NIC's ambassador-and-supporter function at a research-intensive medical school.
• Imperial College London Faculty of Medicine Advisory Groups: External advisory structures supporting Imperial's Faculty of Medicine in research translation and international engagement. Comparable international-academic-medical-center advisory model to NIC.
• Harvard Medical School Board of Fellows: Advisory and ambassadorial body supporting Harvard Medical School, one of the world's leading academic medical centers. Directly comparable to NIC in structure, mission, and convening role for an elite medical school's international supporters.
• Duke University School of Medicine Advisory Board: Advisory board for Duke's medical school supporting research translation and donor engagement. Functionally analogous to NIC as a body that connects influential external leaders with a major academic medical center.
• Johns Hopkins Medicine Board of Advisors: External advisory body supporting Johns Hopkins Medicine across research, education, and clinical missions. Closely matches NIC's role in championing medical research and academic advancement of a flagship medical school.
• Karolinska Institutet External Advisory Boards: External advisory bodies supporting Karolinska Institutet, Sweden's leading medical university. Comparable international academic-medical-center advisory structure to NIC, particularly for cross-border research translation.
• Stanford Medicine Board of Fellows: External advisory council supporting Stanford School of Medicine's research and academic mission. Operates with a comparable convening-and-advocacy remit to NIC at a leading public-research-equivalent institution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/nus-medicine-international-council

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NUS Medicine International Council